- Home
- TRUG vs APM Comparison
TRUG vs APM Comparison
Compare TRUG & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRUG
- APM
- Stock Information
- Founded
- TRUG 1983
- APM 2010
- Country
- TRUG United States
- APM United Kingdom
- Employees
- TRUG N/A
- APM N/A
- Industry
- TRUG
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- TRUG
- APM Health Care
- Exchange
- TRUG NYSE
- APM Nasdaq
- Market Cap
- TRUG 7.0M
- APM 6.9M
- IPO Year
- TRUG N/A
- APM 2018
- Fundamental
- Price
- TRUG $5.78
- APM $1.81
- Analyst Decision
- TRUG Strong Buy
- APM
- Analyst Count
- TRUG 1
- APM 0
- Target Price
- TRUG $100.00
- APM N/A
- AVG Volume (30 Days)
- TRUG 84.7K
- APM 10.1M
- Earning Date
- TRUG 08-13-2025
- APM 08-05-2025
- Dividend Yield
- TRUG N/A
- APM N/A
- EPS Growth
- TRUG N/A
- APM N/A
- EPS
- TRUG N/A
- APM N/A
- Revenue
- TRUG $22,236,072.00
- APM N/A
- Revenue This Year
- TRUG $9.66
- APM N/A
- Revenue Next Year
- TRUG $48.94
- APM N/A
- P/E Ratio
- TRUG N/A
- APM N/A
- Revenue Growth
- TRUG 8.40
- APM N/A
- 52 Week Low
- TRUG $5.00
- APM $0.46
- 52 Week High
- TRUG $73.50
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- TRUG 42.37
- APM 64.19
- Support Level
- TRUG $5.00
- APM $1.40
- Resistance Level
- TRUG $6.80
- APM $1.97
- Average True Range (ATR)
- TRUG 0.72
- APM 0.41
- MACD
- TRUG 0.27
- APM 0.07
- Stochastic Oscillator
- TRUG 22.14
- APM 26.69
About TRUG TRUGOLF HOLDINGS INC
TruGolf Holdings Inc is a indoor golf gaming solutions company. It has built video games (including Links, a sports game for PC), hardware solutions, and an all-new e-sports platform to connect golfers around the world with E6 CONNECT.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.